Biovica enters partnership with IT Health Fusion to commercialise DiviTum TKa assay in Italy
Biovica, a Swedish biotech company founded in 2009 with a vision to improve monitoring and predicting the efficacy of cancer therapies, has signed a commercial partnership agreement with the Italian company, IT Health Fusion, for the commercialization of the DiviTum TKa assay in Italy. In Italy, some 17,000 women are diagnosed with metastatic breast cancer every year. IT Health Fusion, which is a subsidiary of the biotech and pharmaceutical company BIOVIIIx, will lead the Italian market introduction, where the initial focus will be on private insurance and out-of-pocket markets, together constituting some 40 per cent of the Italian market.
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
